In this Issue
PLUS: An update on tricuspid therapies.
Chief Medical Editors’ Page
By Ted E. Feldman, MD, MSCAI, FACC, FESC, and Azeem Latib, MD
What will randomized trials mean for the future of mitral intervention?
By Ted Feldman, MD, FESC, FACC, MSCAI; Paul Sorajja, MD, FACC, FSCAI; Paul Grayburn, MD, FACC, FSCAI; and Francesco Maisano, MD
An appraisal of current and upcoming devices for direct and indirect transcatheter annuloplasty procedures.
By Shingo Kuwata, MD, PhD; and Francesco Maisano, MD
Current and future directions of therapeutic options for patients with degenerative MR.
By Andrea Colli, MD, PhD; Alessandro Fiocco, MD; Nicola Pradegan, MD; Matteo Nadali, MD; Laura Besola, MD; Eleonora Bizzotto, MD; and Gino Gerosa, MD
An emerging frontier with unique anatomic, technical, and clinical challenges.
By Nishtha Sodhi, MD, and Alan Zajarias, MD
A review of the current state of transcatheter tricuspid valve therapies and where they are headed next.
By Antonio Mangieri, MD; Giorgios Tzanis, MD; and Azeem Latib, MD
Essential considerations when expanding your practice.
By Philipp Lurz, MD, PhD; and Mehul B. Patel, MD
Essentials for understanding echocardiographic imaging in percutaneous tricuspid interventions.
By Menhel Kinno, MD, MPH; Sasan R. Raissi, MD; Jyothy J. Puthumana, MD; James D. Thomas, MD; and Charles J. Davidson, MD
FEATURED TECHNOLOGYSponsored by CeloNova BioSciences, Inc.
Discussing the clinical benefits of the COBRA PzF NanoCoated Coronary Stent (NCS).
With Gilles Montalescot, MD, PhD; Axel de Labriolle, MD, PhD; and Donald Cutlip, MD
European Featured TechnologySponsored by REVA Medical
By Gregor Leibundgut, MD
A discussion on the use of patent foramen ovale closure for patients with cryptogenic stroke.
With Lawrence Ong, MD; Salman Azhar, MD; and Jonathan M. Tobis, MD
Dr. Barbanti discusses the background of the FAST-TAVI study, MitraClip implantation, and addressing CAD in patients undergoing TAVI.